VQW-765 (Synonyms: AQW-051) |
| Catalog No.GC70130 |
VQW-765 (AQW-051) is a selective, orally active alpha-7 nicotinic acetylcholine receptor (α7-nAChR) agonist with a pKD value of 7.56 for recombinant human α7-nAChR. VQW-765 exhibits anxiolytic effects in vivo and can be used for research on anxiety disorders and acute anxiety.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 669770-29-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for VQW-765
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for VQW-765
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *